Abstract & Authors:展开
It has been reported that up to half but as low as 3% of COVID-19 patients had gastrointestinal symptoms (e.g., diarrhoea, nausea, and vomiting)1-3 and substantial gut microbiota shifts,4, 5 a testament to the importance of the microbial community in the therapeutic responses and prognosis of the disease. Nevertheless, given the seriously rapid progression of COVID-19,6 it is important to investigate the microbial dynamics during the illness and convalescence stages. Here, we employed a probiotics-assisted therapy to treat a group of COVID-19 patients, and their dynamics of gut microbiota and clinical manifestations were monitored throughout the treatment.
Chunyan Wu,Qian Xu,Zhan Cao
Nan Qin,Hongzhou Lu,Huanlong Qin
Chunyan Wu,Qian Xu,Zhan Cao,Dengdeng Pan,Ying Zhu,Sheng Wang,Danping Liu,Zhigang Song,Wei Jiang,Yumeng Ruan,Yongkun Huang,Nan Qin,Hongzhou Lu,Huanlong Qin